Clinical trial
Ixabepilone + Carboplatin Metastatic Breast Cancer
NCT01075100
Study timeline
Study start (unknown)2010-01-01Date precision: month
Registry last updated2016-12-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metastatic Breast Cancerunresolved
Interventions
IxabepiloneDRUG · verified · RxNorm: ixabepilone
CarboplatinDRUG · verified · RxNorm: carboplatin
Sponsors & collaborators
US Oncology Researchlead sponsor
Bristol-Myers Squibbcollaborator
Mapped research locations
DallasTexas, United States4San AntonioTexas, United States2SpokaneWashington, United States2ColumbiaMissouri, United States2New YorkNew York, United States1HoustonTexas, United States1SeattleWashington, United States1PortlandOregon, United States1PhoenixArizona, United States1MinneapolisMinnesota, United States1DenverColorado, United States1AustinTexas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01075100 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.